Asia Pacific Initiative on Reproduction
ASPIRE is a Singapore-based non-profit professional society, founded in 2001, that delivers reproductive-medicine education and certification through an annual congress, masterclasses, regional meetings, a member-only LMS, and the F&R peer-reviewed journal across the Asia Pacific region.
- Company typePrivate
- Founded2001
- HeadquartersSingapore, Singapore
- Headcount5,001–10,000
- GTM typeB2B
- OfferingServices
What Asia Pacific Initiative on Reproduction does
ASPIRE (Asia Pacific Initiative on Reproduction) is a non-profit professional medical society founded in 2001 in Singapore that serves as the primary multi-country convening body for reproductive medicine practitioners across the Asia Pacific region. Its core offerings are educational and community-oriented: an annual scientific congress that has scaled to 3,000+ delegates from 60 countries (Beijing 2026), a rotating series of masterclasses across major Asia Pacific cities, regional meetings in markets such as Pakistan, India, and Bangladesh, and a recurring EduConnect webinar/webseries/podcast cadence. Supporting these is a member-only Educational Portal (powered by MULTILEARNING Group's MULTIEPORTAL LMS) that archives lecture recordings and tracks CME/MOC/CE accreditation, a tiered embryology certification program (Basic and Intermediate), and the peer-reviewed F&R (Fertility and Reproduction) journal managed via Editorial Manager.
Underlying technology is deliberately narrow and partner-dependent: ASPIRE does not build proprietary clinical or learning technology; instead it consumes MULTILEARNING's LMS, mobile, webcast, testing, ePoster, and submission stack and overlays Google Analytics and Google Tag Manager for behavioral measurement. Revenue mechanics are diversified across five streams: individual and corporate memberships (with a 3-month freemium trial), congress and masterclass registration (USD 450-700 per attendee, member vs. non-member tiers), embryology certification fees, F&R journal manuscript publication fees, and corporate sponsorship from fertility-pharma majors such as Ferring, Merck, and Organon. Strategic authority comes from its Special Interest Groups and country representative network and from co-developing global consensus guidelines on surrogacy alongside ESHRE, ASRM, and IFFS.
Go-to-market is event-driven and community-led rather than commercial: ASPIRE acquires and retains fertility specialists, embryologists, reproductive endocrinologists, nurses, counsellors, and researchers through congresses, SIG programming, and the Educational Portal, distributing via its website, email, Facebook, and Twitter/X (@ASPIRE_2008). The customer base is a long tail of individual healthcare professionals supplemented by a small set of high-value corporate pharma/medtech sponsors; there are no shareholders, equity funding rounds, or investor disclosures, consistent with its non-profit structure.
Asia Pacific Initiative on Reproduction firmographics
Firmographics- Name
- Asia Pacific Initiative on Reproduction
- Legal name
- Asia Pacific Initiative on Reproduction
- Website
- https://aspire-reproduction.org
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- ASPIRE is a Singapore-based non-profit professional society, founded in 2001, that delivers reproductive-medicine education and certification through an annual congress, masterclasses, regional meetings, a member-only LMS, and the F&R peer-reviewed journal across the Asia Pacific region.
- Ownership category
- akta.pro rank
Where Asia Pacific Initiative on Reproduction is headquartered
LocationHeadquarters
- HQ city
- Singapore
- HQ country
- Singapore
- HQ region
- Asia
Markets served
Asia Pacific Initiative on Reproduction business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Membership Fees: ASPIRE generates revenue through individual and corporate membership subscriptions, with tiered access to member benefits including the educational portal, webinars, and reduced congress registration fees.
- Congress and Event Registration: The annual ASPIRE Congress and regional meetings, masterclasses, and webinars generate registration revenue. Fees range from USD 600–700 for full masterclass registration, with member and non-member pricing. The 2025 Congress in Singapore attracted 2,047 delegates from 49 countries.
- Embryology Certification: ASPIRE charges fees for its Basic and Intermediate-level embryology certification programs, including course registration and examination fees.
- F&R Journal Publication: Revenue from manuscript submission fees for the Fertility and Reproduction (F&R) journal, including author guidelines, copyright transfer forms, and online submission via Editorial Manager.
- Corporate Membership and Sponsorship: Corporate members (e.g., Ferring, Merck, Organon) support ASPIRE financially, gaining visibility on the educational portal and at congresses.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Full Masterclass — ASPIRE Member: USD 600, Non-Member: USD 700 |
| Unit Pricing | Pay-as-you-go | Half Masterclass — ASPIRE Member: USD 450, Non-Member: USD 550 |
| Freemium | Monthly | Individual Membership — free trial for 3 months |
| Unit Pricing | Pay-as-you-go | Basic-Level Embryology Certification — registration fee applies |
| Unit Pricing | Pay-as-you-go | Intermediate-Level Embryology Certification — registration fee applies |
Go-to-market motion2 records
Distribution channels6 records
Marketing channels7 records
Asia Pacific Initiative on Reproduction product offering
Product offeringCore offering
ASPIRE is a professional medical society founded in 2001 and headquartered in Singapore that advances reproductive medicine across the Asia Pacific region. It delivers continuing education through an annual world congress, masterclasses, regional meetings, and webinars, and provides an embryology certification program, a peer-reviewed journal (Fertility & Reproduction), and a members-only educational portal serving fertility clinicians, embryologists, nurses, and counselors.
Product overview
ASPIRE (Asia Pacific Initiative on Reproduction) is a professional medical society, not a technology product company. It offers a portfolio of educational and professional development services for fertility specialists across the Asia-Pacific region. The core offerings include the Annual Congress (major scientific conferences), Webinars via EduConnect (live online educational sessions), Masterclass programs (intensive specialized courses), and Regional Meetings (smaller collaborative events with local societies). Supporting these are the Education Portal (a members-only LMS powered by MULTILEARNING containing lecture recordings and resources), the F&R Journal (peer-reviewed publication), and Embryology Certification programs at Basic and Intermediate levels. ASPIRE also runs Awards and Special Interest Groups (SIGs) covering areas such as reproductive endocrinology, endocrinology, embryology, male infertility, and psychology/counselling.
Differentiator
Problem solved
Functional benefit
Brands
- F&R Journal (Fertility and Reproduction): Peer-reviewed journal published by ASPIRE covering reproductive medicine research
- EduConnect
- ASPIRE Education Portal
- ASPIRE Embryology Certification
Products and services
- ASPIRE Annual World Congress Signature annual scientific congress bringing together fertility specialists, embryologists, nurses, counselors, and industry partners across Asia Pacific for scientific exchange, plenary sessions, and networking.
- ASPIRE Masterclass Advanced in-depth training session covering specialized topics in assisted reproductive technology, designed for clinicians seeking deeper expertise in specific reproductive medicine areas.
- ASPIRE Regional Meetings In-person scientific and educational meetings held at country and regional level across Asia Pacific, delivering society programming and clinical updates to local fertility communities.
- EduConnect Webinars Online webinar series delivering virtual continuing education on reproductive medicine topics to ASPIRE members and the broader fertility community.
- ASPIRE Education Portal Members-only learning management system (LMS) hosting on-demand educational videos, lecture recordings, and curated clinical resources for ASPIRE members.
- Fertility & Reproduction (F&R) Journal Peer-reviewed scientific journal publishing original research, reviews, and clinical studies in reproductive medicine for the Asia Pacific fertility community.
- ASPIRE Embryology Certification Program Standardized certification program for clinical embryologists across the Asia Pacific region, validating competence in IVF laboratory techniques and ART laboratory practice.
Quantifiable outcome
- ASPIRE 2025 Congress attracted 2,047 delegates from 49 countries, demonstrating the scale and geographic reach of the society's primary event
- +2 more outcomes
Companies that use Asia Pacific Initiative on Reproduction
Customer profileNamed customers8 records
Segments5 records
Ideal customer profiles2 records
Asia Pacific Initiative on Reproduction technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability2 records
Feature3 records
Asia Pacific Initiative on Reproduction partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered minor and core.
- PCOS Society of IndiaminorASPIRE's 3rd Regional Meeting in India (June 2023) was organized in collaboration with the PCOS Society of India and ISAR (Indian Society for Assisted Reproduction), focusing on the theme 'There is more to PCOS & ART… beyond the obvious'.
- ISAR (Indian Society for Assisted Reproduction)minorASPIRE's 3rd Regional Meeting in India (June 2023) and its 1st Regional Meeting in Pakistan were organized in collaboration with local reproductive medicine societies including ISAR, creating regional professional networks.
- MULTILEARNING Group Inc.coreMULTILEARNING Group Inc. (MLG) powers the ASPIRE Educational Portal — a members-only LMS that archives ASPIRE's educational programs, supports CME/MOC/CE accreditation tracking, and hosts certified courses. MLG acts as data processor for ASPIRE, with some functions as joint controller. MLG's platforms include MULTIEPORTAL LMS, MULTILEARNING Mobile Learning App, MULTIWEBCAST Viewer, MULTITESTER, MULTIEPOSTER Viewer, and MULTISUBMISSION.
- European Society of Human Reproduction and Embryology (ESHRE)coreASPIRE collaborates with ESHRE on global consensus guidelines, including landmark guidelines on minimal standards in surrogacy developed jointly by ASPIRE, ESHRE, ASRM, and IFFS. ASPIRE also holds sessions at ESHRE's annual meetings (e.g., ASPIRE Session @ ESHRE 42nd Annual Meeting).
- American Society for Reproductive Medicine (ASRM)coreASPIRE collaborates with ASRM as part of a global partnership including ESHRE and IFFS to develop and finalize global consensus guidelines on minimal standards in surrogacy, addressing human rights violations and ensuring welfare of all parties involved in surrogacy arrangements.
- International Federation of Fertility Societies (IFFS)coreASPIRE collaborates with IFFS on global consensus guidelines and educational programs. ASPIRE's Prof. Luca Gianaroli serves as Director of Global Educational Programs at IFFS, creating a direct link between ASPIRE and IFFS educational initiatives.
- Global Andrology ForumminorASPIRE has established close links with the Global Andrology Forum as part of its network of international bodies working in assisted reproduction. ASPIRE's President Dr Haroon Latif has noted this partnership as part of ASPIRE's expanding international collaboration.
- Emory University (USA)minorBirdem General Hospital in Dhaka, Bangladesh, collaborated with Emory University in a study on the decline in semen parameters among Bangladeshi men. The study, presented at ASPIRE 2026, found increasing trends of azoospermia over two decades.
- Taiwan IVF Group and Ton Yen General Hospital, Taiwan (China)minorThe Taiwan IVF Group and Ton Yen General Hospital collaborated with Stanford University (USA) on a major study identifying South and East Asia as hotspots of global warming-related impacts on male fertility. The study was presented at the ASPIRE 2026 Congress.
- Ferring PharmaceuticalsminorFerring Pharmaceuticals is featured as a corporate member logo on the ASPIRE Educational Portal footer. As a corporate member, Ferring supports ASPIRE's educational programs and gains visibility on the portal and at ASPIRE events.
- MerckminorMerck is featured as a corporate member logo on the ASPIRE Educational Portal footer. As a corporate member, Merck supports ASPIRE's educational programs and gains visibility on the portal and at ASPIRE events.
- OrganonminorOrganon is featured as a corporate member logo on the ASPIRE Educational Portal footer. As a corporate member, Organon supports ASPIRE's educational programs and gains visibility on the portal and at ASPIRE events.
Scale indicators11 records
Recent moves6 records
Expansion highlights6 records
Asia Pacific Initiative on Reproduction competitors and assessment
Company assessmentRegional players
- Middle East Fertility Society (MEFS): Regional reproductive medicine society serving the Middle East. Comparable in mission (CME, annual congress, regional guidelines) but geographically distinct from ASPIRE's Asia Pacific footprint.
- Fertility Society of Australia and New Zealand (FSANZ): Australia/New Zealand regional fertility society. Comparable in annual scientific meeting, certification, and member services; co-hosted ASPIRE's 2014 Brisbane congress and serves an overlapping Asia Pacific audience.
- Indian Society for Assisted Reproduction (ISAR): India's national ART professional society. Co-organizes ASPIRE's regional meetings (e.g., 2023 India meeting with PCOS Society of India); comparable in CME, congress, and member-driven structure but operates within a single country.
- Japan Society of Fertility and Implantation (JSFI): Japan's national fertility society. Comparable as a country-level reproductive-medicine professional society; ASPIRE runs sessions at JSFI's annual meeting and Prof. Osuga chairs ASPIRE 2027 Yokohama's local organizing committee.
- Red Latinoamericana de Reproducción Asistida (REDLARA): Latin American network of assisted reproduction centers. Comparable as a regional reproductive-medicine organization running congresses, certification, and accreditation programs, but serving a different geography than ASPIRE.
Direct peers
- European Society of Human Reproduction and Embryology (ESHRE): Europe's leading professional society in reproductive medicine. Directly comparable as ASPIRE's counterpart for the European region, co-develops global consensus guidelines with ASPIRE, and runs an annual congress with similar scientific, education, and certification functions.
- American Society for Reproductive Medicine (ASRM): The principal US professional society for reproductive medicine. Directly comparable in mission and product mix (annual congress, journal Fertility and Sterility, practice guidelines, CME), and a co-developer with ASPIRE of global surrogacy consensus guidelines.
Emerging players
- PCOS Society of India: India-based society focused on Polycystic Ovary Syndrome. Co-organized ASPIRE's 2023 India Regional Meeting; partial overlap on reproductive endocrinology content and clinician audience.
- Global Andrology Forum: International community focused on male infertility and andrology. Adjacent to ASPIRE's Male Infertility SIG; ASPIRE's President has publicly noted this as a strategic partnership, indicating thematic and audience overlap.
Broad incumbents
- International Federation of Fertility Societies (IFFS): Global umbrella body for national fertility societies. Overlapping mission with ASPIRE in consensus guidelines and education; ASPIRE's Prof. Gianaroli serves as IFFS Director of Global Educational Programs, evidencing deep institutional linkage.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Asia Pacific Initiative on Reproduction social profiles
Digital presenceAsia Pacific Initiative on Reproduction compliance and trust
Trust signalCompliance1 record
Asia Pacific Initiative on Reproduction financial estimates
Financial estimateRevenue estimate
Valuation estimate
Asia Pacific Initiative on Reproduction leadership team
Management profileNumber of profiles
Profiles3 records
Asia Pacific Initiative on Reproduction funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Asia Pacific Initiative on Reproduction M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Asia Pacific Initiative on Reproduction
What does Asia Pacific Initiative on Reproduction do?
ASPIRE is a professional medical society founded in 2001 and headquartered in Singapore that advances reproductive medicine across the Asia Pacific region. It delivers continuing education through an annual world congress, masterclasses, regional meetings, and webinars, and provides an embryology certification program, a peer-reviewed journal (Fertility & Reproduction), and a members-only educational portal serving fertility clinicians, embryologists, nurses, and counselors.
Is Asia Pacific Initiative on Reproduction a public or private company?
Asia Pacific Initiative on Reproduction is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Asia Pacific Initiative on Reproduction founded?
Asia Pacific Initiative on Reproduction was founded in 2001. It employs 5,001 to 10,000 people.
Where is Asia Pacific Initiative on Reproduction based?
Asia Pacific Initiative on Reproduction is headquartered in Singapore, Singapore, in the Asia region.
How does Asia Pacific Initiative on Reproduction make money?
Five revenue lines are on record. Membership Fees are the primary driver. The others are congress and Event Registration, embryology Certification, F&R Journal Publication and corporate Membership and Sponsorship.
Who are Asia Pacific Initiative on Reproduction's main competitors?
Regional players on record are Middle East Fertility Society (MEFS), Fertility Society of Australia and New Zealand (FSANZ), Indian Society for Assisted Reproduction (ISAR), Japan Society of Fertility and Implantation (JSFI) and Red Latinoamericana de Reproducción Asistida (REDLARA). Direct peers are European Society of Human Reproduction and Embryology (ESHRE) and American Society for Reproductive Medicine (ASRM). Emerging players are PCOS Society of India and Global Andrology Forum. International Federation of Fertility Societies (IFFS) is listed as a broad incumbent.
Does Asia Pacific Initiative on Reproduction have an API?
No public API is recorded for Asia Pacific Initiative on Reproduction.